CD26-antigen-inhibitorsBullous pemphigoid: 17 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1819卷 / 1期

关键词：

D O I：

10.1007/s40278-020-82620-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：77 / 77

相关论文

共 50 条

[21] PembrolizumabSevere bullous pemphigoid and lichen planus pemphigoid: 2 case reports
Reactions Weekly, 2023, 1939 (1) : 379 - 379
[22] Bimekizumab/IxekizumabBullous pemphigoid : 2 case reports
Reactions Weekly, 2024, 2024 (1) : 97 - 97
[23] Linagliptin/vildagliptinBullous pemphigoid: 3 case reports
Reactions Weekly, 2019, 1756 (1) : 212 - 212
[24] Multiple drugsBullous pemphigoid: 14 case reports
Reactions Weekly, 2021, 1862 (1) : 315 - 315
[25] Everolimus/sirolimusBullous pemphigoid: 2 case reports
Reactions Weekly, 2016, 1583 (1) : 485 - 485
[26] Multiple drugsBullous pemphigoid: 10 case reports
Reactions Weekly, 2021, 1880 (1) : 255 - 255
[27] Multiple drugsBullous pemphigoid: 42 case reports
Reactions Weekly, 2017, 1633 (1) : 519 - 519
[28] Dyshidrosiform Bullous Pemphigoid: Case Reports and Review
Cohen, Philip R.
CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (01)
[29] Nivolumab/pembrolizumabNonbullous pemphigoid: 4 case reports
Reactions Weekly, 2019, 1776 (1) : 335 - 335
[30] VaccinesBullous pemphigoid in infants: 3 case reports
Reactions Weekly, 2014, 1487 (1) : 34 - 34

← 1 2 3 4 5 →